Please Wait.....
Report
North America Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
Market Report I 2023-09-14 I 129 Pages I The Insight Partners
The North America bioprocess technology market is expected to grow from US$ 15,869.06 million in 2023 to US$ 33,696.06 million by 2028. It is estimated to grow at a CAGR of 16.3% from 2023 to 2028.
Increasing Prevalence of Chronic Diseases Drives North America Bioprocess Technology Market
The unprecedented rate of aging population and extended periods of physical inactivity are boosting the prevalence lifestyle disorders, such as obesity and diabetes. Genes can cause conditions such as cardiovascular disease (CVDs), diabetes, obesity, Alzheimer's disease, and depression. According to the National Council on Aging, Inc., 80% of adults (aged 65 and more) are reported to suffer from at least one chronic condition in their lifetime, while 68% have two or more. According to the Centers for Disease Control and Prevention (CDC), nearly 6 of 10 people in the US suffered from at least one serious disease, and 4 of 10 people have had two or more chronic conditions in 2020. CVDs, such as angina pectoris, atherosclerosis, and acute myocardial infarction, caused due to hectic lifestyles are significant causes of mortality across the region. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can cause various complications in different body parts, thereby increasing the overall risk of death. Heart attack, kidney failure, stroke, leg amputation, nerve damage, and vision loss are among the major complications associated with diabetes. According to the International Diabetes Federation (IDF), diabetic cases in North America are expected to reach 62 million by 2045 from 46 million in 2017. The data further reported that 425 million people suffered from diabetes in 2017, and the count is likely to reach 629 million by 2045 worldwide. The disease prevalence is likely to increase by about 35% during the forecast period. Recognition of biosimilars as efficacious and safe agents by patients, specialists, primary care clinicians, and other healthcare professionals is propelling its demand. Biosimilars have proven to improve the quality of life for millions of patients. They are effective and cost-effective options in treating many diseases, including chronic skin conditions (such as psoriasis, Atopic Dermatitis), bowel diseases (such as Crohn's disease, irritable bowel syndrome, and colitis), diabetes, autoimmune disease, cancer, kidney conditions, and arthritis. Biosimilar developers are adopting advanced bioprocessing technologies to achieve lower manufacturing costs, an important factor determining final consumer prices. Nearly all biosimilar developers are using modern, often cutting-edge bioprocessing techniques. This indicates that a majority of biosimilars are being developed using single use (disposed of after-use) bioprocessing systems. With the growing prevalence of chronic diseases, the demand for biosimilars to treat life-threatening illnesses is spurring, thereby propelling the demand for bioprocessing technologies.
North America Bioprocess Technology Market Overview
According to the Food and Drug Administration (FDA) report, over 30 million people in the US suffer from ~7,000 rare diseases, accounting for life-threatening conditions with low treatment options. Drug, biological, and device development in the treatment of rare diseases is challenging due to a lack of understanding of the history of rare diseases and difficulty in conducting clinical trials. Therefore, the growth of bioprocess technologies such as gene and cell therapies (CGTs) and specialty pharmaceuticals represent a radical shift in the treatment of rare diseases. For example, CGTs have revealed significant health benefits than formulated drugs for treating rare diseases. In the US, more than 900 investigational new drug (IND) applications targeting gene therapy products are underway. Also, 10-20 gene therapies are approved annually by the FDA. Likewise, in August 2022, the FDA approved Bluebird Bio's "Zynteglo (betibeglogene autotemcel)." It was the most expensive single-application drug approval in the US intended for the treatment of a rare neurological disorder-cerebral adrenoleukodystrophy (CALD).
North America Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)
North America Bioprocess Technology Market Segmentation
The North America bioprocess technology market is segmented into type, modality, end user, and country.
Based on type, the North America bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. In 2023, the cell culture media bioprocess segment registered a largest share in the North America bioprocess technology market.
Based on modality, the North America bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the North America bioprocess technology market.
Based on end-use, the North America bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered a largest share in the North America bioprocess technology market.
Based on country, the North America bioprocess technology market is segmented into the US, Canada, and Mexico. In 2023, the US segment registered a largest share in the North America bioprocess technology market.
Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; STAMM Biotech; and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America bioprocess technology market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Bioprocess Technology Market - by Type
1.3.2 North America Bioprocess Technology Market - by Modality
1.3.3 North America Bioprocess Technology Market - by End User
1.3.1 North America Bioprocess Technology Market - by Country
2. North America Bioprocess Technology Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioprocess Technology Market - Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert's Opinion
5. North America Bioprocess Technology Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
5.5 Impact Analysis
6. Bioprocess Technology Market - North America Analysis
6.1 North America Bioprocess Technology Market Revenue Forecast and Analysis
7. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type
7.1 Overview
7.2 North America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
7.3.1 Overview
7.3.2 Cell Culture Media Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
7.4.1 Overview
7.4.2 Chromatography Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
7.5.1 Overview
7.5.2 Consumables & Accessories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality
8.1 Overview
8.2 North America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
8.3.1 Overview
8.3.2 Single Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
8.4.1 Overview
8.4.2 Multiple Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User
9.1 Overview
9.2 North America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
9.3.1 Overview
9.3.2 Academic & Medical Institutions: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
9.4.1 Overview
9.4.2 Biopharmaceutical Companies: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis
10.1 North America: Bioprocess Technology Market
10.1.1 Overview
10.1.2 North America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.1.2.1 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.2.1.4 US: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.2.1.5 US: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.2.2.4 Canada: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.2.2.5 Canada: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.2.3 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.2.3.4 Mexico: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.2.3.5 Mexico: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
11. North America Bioprocess Technology Market - Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sartorius AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Corning Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 STAMM Biotech
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Lonza Group AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Eppendorf SE
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Repligen Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Danaher Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. US Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 12. Recent Inorganic Growth Strategies in the North America bioprocess technology market
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Bioprocess Technology Market Segmentation
Figure 2. North America Bioprocess Technology Market, by Country
Figure 3. North America Bioprocess Technology Market Overview
Figure 4. Cell Culture Media Bioprocess Segment Held Largest Share of Type Segment in North America Bioprocess Technology Market
Figure 5. Canada Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. North America Bioprocess Technology Market Impact and Analysis
Figure 9. North America Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. North America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security